Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 09, 2025 07:00 ET | Source: IN8bio, Inc

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial
June 02, 2025 07:30 ET | Source: IN8bio, Inc

IN8bio Presents Positive Phase 1 Data of INB-200 in Newly Diagnosed GBM Demonstrating Prolonged Progression-Free Survival

IN8bio Presents Positive Phase 1 Data of INB-200 in Newly Diagnosed GBM Demonstrating Prolonged Progression-Free Survival
May 14, 2025 08:00 ET | Source: IN8bio, Inc

IN8bio Presents Preclinical Data Highlighting Potential of INB-619 T Cell Engager (TCE) for Autoimmune Disease at ASGCT 2025

IN8bio Presents Preclinical Data Highlighting Potential of INB-619 T Cell Engager (TCE) for Autoimmune Disease at ASGCT 2025
May 12, 2025 08:00 ET | Source: IN8bio, Inc

IN8bio Presents Data at ISCT 2025 Demonstrating Proprietary γδ T cell Manufacturing Generates Consistent and Robust Clinical Products

IN8bio Presents Data at ISCT 2025 Demonstrating Proprietary γδ T cell Manufacturing Generates Consistent and Robust Clinical Products
May 07, 2025 16:00 ET | Source: IN8bio, Inc

IN8bio Reports First Quarter 2025 Financial Results and Recent Business Highlights

IN8bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
April 29, 2025 08:00 ET | Source: IN8bio, Inc

IN8bio to Present Clinical and Preclinical Data from Gamma-Delta T Cell Platform at Upcoming Scientific Conferences

IN8bio to Present Clinical and Preclinical Data from Gamma-Delta T Cell Platform at Upcoming Scientific Conferences
April 28, 2025 08:00 ET | Source: IN8bio, Inc

IN8bio Unveils Promising New Data from Next Generation Gamma-Delta T Cell Engager (TCE) Platform at AACR 2025

IN8bio Unveils Promising New Data from Next Generation Gamma-Delta T Cell Engager (TCE) Platform at AACR 2025
March 31, 2025 08:00 ET | Source: IN8bio, Inc

IN8bio to Present New Preclinical Data on Novel Gamma-Delta (γδ) T cell Engager Platform for Cancer Immunotherapy at AACR Annual Meeting 2025

IN8bio to Present New Preclinical Data on Novel Gamma-Delta (γδ) T cell Engager Platform for Cancer Immunotherapy at AACR Annual Meeting 2025
March 18, 2025 08:05 ET | Source: IN8bio, Inc

IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conference 2025

IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conference 2025
March 13, 2025 16:05 ET | Source: IN8bio, Inc

IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

IN8bio Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

Next Page keyboard_arrow_right